SRAMF (Sisram Medical) OCF Margin %: 7.15% (As of Dec. 2025) — 38% Below Median


SRAMF Sisram Medical Ltd SRAMF
60 GF Score
Price $0.44
GF Value $0.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sisram Medical OCF Margin %?

Sisram Medical SRAMF 60 OCF Margin % is 7.15% as of Dec. 2025, which is 38% below its 10-year median of 11.56. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Sisram Medical ranks worse than 57.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Sisram Medical's Cash Flow from Operations for the six months ended in Dec. 2025 was $14.3 Mil. Sisram Medical's Revenue for the six months ended in Dec. 2025 was $199.9 Mil. Therefore, Sisram Medical's OCF Margin % for the quarter that ended in Dec. 2025 was 7.15%.

As of today, Sisram Medical's current OCF Yield % is 6.94%.

The historical rank and industry rank for Sisram Medical's OCF Margin % or its related term are showing as below:

SRAMF' s OCF Margin % Range Over the Past 10 Years
Min: 2.57   Med: 11.56   Max: 15.88
Current: 2.57


During the past 12 years, the highest OCF Margin % of Sisram Medical was 15.88%. The lowest was 2.57%. And the median was 11.56%.

SRAMF's OCF Margin % is ranked worse than
57.18% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs SRAMF: 2.57


Sisram Medical OCF Margin % Related Terms


Sisram Medical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Sisram Medical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sisram Medical OCF Margin % Chart

Sisram Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.00 6.22 12.23 9.48 2.57

Sisram Medical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.14 2.35 16.14 -2.96 7.15

SRAMF vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Sisram Medical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sisram Medical OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Sisram Medical's OCF Margin % falls into.


SRAMF
60GF Score
Sisram Medical Ltd SRAMF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sisram Medical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Sisram Medical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=9.398/365.347
=2.57 %

Sisram Medical's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=14.289/199.871
=7.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 7.15% mean?
Sisram Medical (SRAMF) has a OCF Margin % of 7.15% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sisram Medical and its competitors. This is 38% below median its historical median of 11.56. Over the past decade, Sisram Medical's OCF Margin % has ranged from 2.57 to 15.88. According to the industry distribution chart, Sisram Medical ranks #466 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 57.2%.
Is Sisram Medical's OCF Margin % too high?
Sisram Medical's current OCF Margin % of 7.15% is 38% below median its 10-year median of 11.56. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 15.88. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Sisram Medical's value of 7.15% is 22% above this industry median. Based on the distribution chart, Sisram Medical ranks #466 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sisram Medical ranks #466 out of 815 companies for OCF Margin %. This places Sisram Medical in the lower half of its industry. The industry median OCF Margin % is 5.86. Sisram Medical's value of 7.15% is 22% above this benchmark. Historically, Sisram Medical's own OCF Margin % has ranged from 2.57 to 15.88 over the past decade. While the company's 10-year median is 11.56 vs. the industry median of 5.86, Sisram Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sisram Medical's current OCF Margin % of 7.15% is 22% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sisram Medical and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sisram Medical's current OCF Margin % is 7.15%, which is 38% below median its own 10-year median of 11.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.95, compared to a current price of $0.44 — trading 53.9% below its estimated fair value. The current OCF Margin % is 7.15%, which is 38% below median its 10-year median of 11.56 and 22% above the Medical Devices & Instruments industry median of 5.86. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current OCF Margin % is 7.15% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sisram Medical (SRAMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued. The current stock price of $0.44 is trading 53.9% below its estimated GF Value™ of $0.95. GuruFocus considers Sisram Medical to be Significantly Undervalued.

Key valuation signals for SRAMF:

  • OCF Margin %: 7.15% (38% below median its 10-year median of 11.56)
  • GF Value™: $0.95 vs. price of $0.44 (53.9% below fair value)
  • GF Score™: 60/100 with 5 warning signs
  • Industry Position: 22% above the Medical Devices & Instruments median (#466 of 815)

No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sisram Medical Business Description

Other Exchanges 01696:Hong Kong
Address HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score

Get the complete analysis for SRAMF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.95
GF Value